• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".

作者信息

Bertoletti Antonio, Tan Anthony T

机构信息

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.

出版信息

Clin Mol Hepatol. 2025 Jan;31(1):e113-e116. doi: 10.3350/cmh.2024.0867. Epub 2024 Oct 11.

DOI:10.3350/cmh.2024.0867
PMID:39391912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11791601/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d48e/11791601/e2e7dbaf9692/cmh-2024-0867f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d48e/11791601/e2e7dbaf9692/cmh-2024-0867f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d48e/11791601/e2e7dbaf9692/cmh-2024-0867f1.jpg

相似文献

1
Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".对关于“基因改造、重定向T细胞在临床环境中靶向乙型肝炎表面抗原阳性肝细胞和肝细胞癌病变”的信件的回复
Clin Mol Hepatol. 2025 Jan;31(1):e113-e116. doi: 10.3350/cmh.2024.0867. Epub 2024 Oct 11.
2
Correspondence to editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".致关于“基因改造、重定向T细胞在临床环境中靶向乙型肝炎表面抗原阳性肝细胞和肝细胞癌病变”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e44-e47. doi: 10.3350/cmh.2024.0781. Epub 2024 Oct 21.
3
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.在临床环境中，基因修饰、重定向的 T 细胞靶向乙型肝炎表面抗原阳性的肝细胞和肝癌病变。
Clin Mol Hepatol. 2024 Oct;30(4):735-755. doi: 10.3350/cmh.2024.0058. Epub 2024 May 29.
4
Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".工程化乙肝病毒特异性T细胞用于治疗乙肝相关肝癌和乙肝感染：过去、现在与未来。关于“基因改造的重定向T细胞在临床环境中靶向乙肝表面抗原阳性肝细胞和肝细胞癌病灶”的社论
Clin Mol Hepatol. 2024 Oct;30(4):728-734. doi: 10.3350/cmh.2024.0469. Epub 2024 Jun 27.
5
T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.重新定向针对乙型肝炎病毒表面蛋白的T细胞可消除受感染的肝细胞。
Gastroenterology. 2008 Jan;134(1):239-47. doi: 10.1053/j.gastro.2007.11.002. Epub 2007 Nov 4.
6
Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.电穿孔信使 RNA 乙型肝炎病毒 (HBV) 抗原特异性 T 细胞受体 (TCR) 重定向 T 细胞治疗在肝移植后复发 HBV 相关肝细胞癌患者中耐受性良好：I 期试验结果。
Hepatol Int. 2023 Aug;17(4):850-859. doi: 10.1007/s12072-023-10524-x. Epub 2023 Apr 17.
7
Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future.乙型肝炎病毒相关肝细胞癌的靶向治疗：现状与未来
Diseases. 2016 Feb 15;4(1):10. doi: 10.3390/diseases4010010.
8
T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.表达嵌合抗原受体的 T 细胞能结合乙型肝炎病毒包膜蛋白，从而控制小鼠体内病毒复制。
Gastroenterology. 2013 Aug;145(2):456-65. doi: 10.1053/j.gastro.2013.04.047. Epub 2013 Apr 30.
9
Localization of hepatitis B surface and core antigens in human hepatocellular carcinoma by immunoperoxidase methods. Replication of complete virions of carcinoma cells.应用免疫过氧化物酶法对人肝细胞癌中乙型肝炎表面抗原和核心抗原进行定位。癌细胞中完整病毒粒子的复制。
Cancer. 1985 Jul 15;56(2):321-7. doi: 10.1002/1097-0142(19850715)56:2<321::aid-cncr2820560220>3.0.co;2-d.
10
Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.Ⅱ型磨玻璃样肝细胞作为慢性乙型肝炎肝细胞癌的标志物。
Hum Pathol. 2013 Aug;44(8):1665-71. doi: 10.1016/j.humpath.2013.01.020. Epub 2013 Apr 8.

本文引用的文献

1
Correspondence to editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".致关于“基因改造、重定向T细胞在临床环境中靶向乙型肝炎表面抗原阳性肝细胞和肝细胞癌病变”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e44-e47. doi: 10.3350/cmh.2024.0781. Epub 2024 Oct 21.
2
A rapid method to assess the multi-functionality of adoptively transferred engineered TCR T cells.一种评估过继转移工程化TCR T细胞多功能性的快速方法。
Immunother Adv. 2024 Sep 18;4(1):ltae007. doi: 10.1093/immadv/ltae007. eCollection 2024.
3
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection.
肝脏免疫调节装置调控慢性乙型肝炎病毒感染中的 CD8 T 细胞免疫。
Nature. 2024 Jul;631(8022):867-875. doi: 10.1038/s41586-024-07630-7. Epub 2024 Jul 10.
4
Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".工程化乙肝病毒特异性T细胞用于治疗乙肝相关肝癌和乙肝感染：过去、现在与未来。关于“基因改造的重定向T细胞在临床环境中靶向乙肝表面抗原阳性肝细胞和肝细胞癌病灶”的社论
Clin Mol Hepatol. 2024 Oct;30(4):728-734. doi: 10.3350/cmh.2024.0469. Epub 2024 Jun 27.
5
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.在临床环境中，基因修饰、重定向的 T 细胞靶向乙型肝炎表面抗原阳性的肝细胞和肝癌病变。
Clin Mol Hepatol. 2024 Oct;30(4):735-755. doi: 10.3350/cmh.2024.0058. Epub 2024 May 29.
6
Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases.迈向低成本基因治疗：基于 mRNA 的疗法治疗遗传性视网膜疾病。
Trends Mol Med. 2024 Feb;30(2):136-146. doi: 10.1016/j.molmed.2023.11.009. Epub 2023 Dec 2.
7
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells.用经mRNA电穿孔的HBV-TCR T细胞治疗HBV相关肝癌。
Immunother Adv. 2021 Dec 24;2(1):ltab026. doi: 10.1093/immadv/ltab026. eCollection 2022.
8
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC.免疫治疗后短暂存活的 HBV-TCR T 细胞的免疫改变与 HBV-HCC 的长期治疗反应相关。
Hepatol Commun. 2022 Apr;6(4):841-854. doi: 10.1002/hep4.1857. Epub 2021 Dec 21.
9
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.乙型肝炎表面抗原对慢性乙型肝炎病毒感染患者病毒特异性和整体 T 细胞的影响。
Gastroenterology. 2020 Aug;159(2):652-664. doi: 10.1053/j.gastro.2020.04.019. Epub 2020 Apr 14.
10
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.利用整合到肝癌细胞基因组中的 HBV-DNA 的表达谱来选择用于免疫治疗的 T 细胞。
Gastroenterology. 2019 May;156(6):1862-1876.e9. doi: 10.1053/j.gastro.2019.01.251. Epub 2019 Jan 31.